Functional nutrition option patients with non-alcoholic fatty liver disease
https://doi.org/10.31146/1682-8658-ecg-218-10-189-196
Abstract
The results of a study of the clinical efficacy of dietary treatment in patients with non-alcoholic liver disease (NAFLD) with the additional inclusion of a new specialized nutritional functional dietary product “A mixture of essential nutrients multicomponent dry” (SENMS) in the product content of the standard D3 diet are presented. 75 patients with NAFLD were examined (39 - study group, 36 - control group). The patients in the study group received 6 g of SENMS daily for 2 weeks, consisting of 6 ingredients that are sources of biologically active substances: inulin, green tea extract, dry red wine extract, L-carnitine, grape seed extract, coenzyme Q10. As a result of the conducted study, it was proved that the SEMS in patients with NAFLD contributed to a faster decrease in the severity of hepatic parenchymal inflammation compared with the control, improved cholesterol metabolism, lipid peroxidation, and quality of life indicators of patients. In conclusion, the expediency of using a new specialized functional dietary food product “A mixture of essential nutrients multicomponent dry” in dietary treatment programs for patients with NAFLD was noted.
About the Authors
A. Yu. Baranovsky
Saint-Petersburg State University
Russian Federation
Russian Federation
N. A. Kruglova
Saint-Petersburg State University
Russian Federation
Russian Federation
E. Yu. Grigoreva
Saint-Petersburg State University
Russian Federation
Russian Federation
References
1. Baranovsky A. Yu. Dietetics. 5th edition. St. Petersburg. Peter Publ., 2017, 1104 p. (in Russ.)@@ Диетология. 5-е изд./под ред. А. Ю. Барановского. - СПб: Питер, 2017, 1104 с.
2. Ivashkin V. T., Maevskaya M. V., Zharkova M. S. et al. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(4):104-140. (in Russ.) doi: 10.22416/1382-4376-2022-32-4-104-140.@@ Ивашкин В. Т., Маевская М. В., Жаркова М. С. и др. Клинические рекомендации Российского общества по изучению печени, Российской гастроэнтерологической ассоциации, Российской ассоциации эндокринологов, Российской ассоциации геронтологов и гериатров и Национального общества профилактической кардиологии по диагностике и лечению неалкогольной жировой болезни печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022;32(4):104-140. doi: 10.22416/1382-4376-2022-32-4-104-140.
3. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004.
4. Parthasarathy G., Revelo X., Malhi H. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. Hepatol Commun. 2020 Jan 14;4(4):478-492. doi: 10.1002/hep4.1479.
5. Haas J. T., Francque S., Staels B. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. Annu Rev Physiol. 2016;78:181-205. doi: 10.1146/annurev-physiol-021115-105331.
6. Drapkina O. M., Bueverov A. O. [Non-alcoholic fatty disease as a multidisciplinary pathology]. Moscow. Publishing house «Vidoks», 2019, 104 p. (in Russ.)@@ Драпкина О. М., Буеверов А. О. Неалкогольная жировая болезнь как мультидисциплинарная патология. М.: Изд-во «Видокс», 2019, 104 с.
7. Buzzetti E., Pinzani M., Tsochatzis E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012.
8. Schiff Y. R., Sorrell M. F., Maddray W. S. Alcohol, drug, genetic and metabolic diseases; Transl. from English. Moscow. GEOTAR-Media Publ., 2011. 476 p. (in Russ.)@@ Шифф Ю. Р., Соррел М. Ф., Мэддрей У. С. Алкогольные, лекарственные, генетические и метаболические заболевания; пер. с англ. М.: ГЭОТАР-Медиа, 2011. 476 с.
9. Dulloo A. G., Duret C., Rohrer D., Girardier L., Mensi N., Fathi M., Chantre P., Vandermander J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999 Dec;70(6):1040-5. doi: 10.1093/ajcn/70.6.1040.
10. Maron D. J., Lu G. P., Cai N. S. et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003 Jun 23;163(12):1448-53. doi: 10.1001/archinte.163.12.1448.
11. Binfaré R. W., Rosa A. O., Lobato K. R. et al. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):530-40. doi: 10.1016/j.pnpbp.2009.02.003.
12. Hlavati M., Tomić S., Buljan K., Buljanović V., Feldi I, Butković-Soldo S. Total Antioxidant Status in Stable Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2020 Oct 6;15:2411-2419. doi: 10.2147/COPD.S264944.
13. Scalbert A., Manach C., Morand C. et al. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005;45(4):287-306. doi: 10.1080/1040869059096.
14. Vauzour D., Rodriguez-Mateos A., Corona G., Oruna-Concha M. J., Spencer J. P. Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients. 2010 Nov;2(11):1106-31. doi: 10.3390/nu2111106.
15. Nicholson S. K., Tucker G. A., Brameld J. M. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc. 2008 Feb;67(1):42-7. doi: 10.1017/S0029665108006009.
16. Shrime M. G., Bauer S. R., McDonald A. C., Chowdhury N. H., Coltart C. E., Ding E. L. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr. 2011 Nov;141(11):1982-8. doi: 10.3945/jn.111.145482.
17. Tsukamoto H., Lew G., Larkin E. C. et al. Hepatic origin of triglycerides in fatty livers produced by the continuous intragastric infusion of an ethanol diet. Lipids. 1984 Jun;19(6):419-22. doi: 10.1007/BF02537403.
18. Spaniol M., Kaufmann P., Beier K., Wüthrich J., Török M., Scharnagl H., März W., Krähenbühl S. Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. J Lipid Res. 2003 Jan;44(1):144-53. doi: 10.1194/jlr.m200200-jlr200.
19. Nagornaya N. V., Chetverik N. A. Oxidative stress: impact on the human body, assessment methods. Child’s Health. 2010, pp. 140-145. (in Russ.)@@ Нагорная, Н.В., Четверик, Н. А. Оксидативный стресс: влияние на организм человека, методы оценки // Здоровье ребенка. 2010. С. 140-145.
20. Buzzetti E., Pinzani M., Tsochatzis E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012.
21. Li A. N., Li S., Zhang Y. J., Xu X. R., Chen Y. M., Li H. B. Resources and biological activities of natural polyphenols. Nutrients. 2014 Dec 22;6(12):6020-47. doi: 10.3390/nu6126020.
22. Medina J., Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs. 2005;65(17):2445-61. doi: 10.2165/00003495-200565170-00003.
23. Davison K. M., Temple N. J. Cereal fiber, fruit fiber, and type 2 diabetes: Explaining the paradox. J Diabetes Complications. 2018 Feb;32(2):240-245. doi: 10.1016/j.jdiacomp.2017.11.002.
24. Zhao L., Zhang F., Ding X. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018 Mar 9;359(6380):1151-1156. doi: 10.1126/science.aao5774.
25. Ryan M. C., Itsiopoulos C., Thodis T. et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013 Jul;59(1):138-43. doi: 10.1016/j.jhep.2013.02.012.
Review
For citations:
Baranovsky A.Yu., Kruglova N.A., Grigoreva E.Yu. Functional nutrition option patients with non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology. 2023;(10):189-196. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-218-10-189-196
Views:
134
Email this article 